ArticleNature communications2019

Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes.

Karl E Carlström et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.